BioSpace News Archive

50% Reduction in Health Costs One Year Post-Treatment Also Demonstrated

--Team Led by Nationally-Known Biotech and Natural Foods Entrepreneurs Launches BiomeBlissTM, First-in-Class Product to Nourish, Shift and Protect the GI Microbiome-- --Scientifically-Developed Blend of Prebiotic and Other Natural Ingredients in Convenient, Tasty Low-Calorie Drink Format Now Available to Consumers Nationwide--

Launching one of the first SEC-compliant ICO security offerings

Social Security numbers are coming off Medicare cards beginning April 1 but Massachusetts residents won’t see their new cards for several months

Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that its board of directors has declared a regular quarterly dividend of 40 cents per share, an increase of 6.7 percent over the year-ago period.

The trial is sponsored by the US National Institute of Allergy and Infectious Disease.

Developed in strategic partnership with Transitions Optical, this one-of-a-kind contact lens corrects vision and adapts to changing light conditions

Today, in Canada, Novo Nordisk announced the launch and availability of Rebinyn® (Coagulation Factor IX (Recombinant), pegylated), an anti-hemophilic factor indicated in adults and children with hemophilia B (congenital factor IX deficiency or Christmas disease) for control and prevention of bleeding episodes and control and prevention of bleeding in the perioperative setting

Cambia Health Solutions and Livongo Health announced a strategic partnership that combines Cambia’s vision to redesign health and health care to be more consumer-driven with Livongo’s proven ‘whole person’ approach to empowering people with chronic conditions to live better and healthier lives.

Financing round led by Third Point Ventures, with participation by Paladin Capital Group and Vital Venture Capital.